4 results for “Time Reversal TR”

Set a search alert

Research ArticleOpen accessIn the keywordsEnergy Efficiency Analysis of a TR-UWB SystemAdil El Abboubi, Fouzia Elbahhar, Marc Heddebaut et al.In wireless communications, where sensors operate on batteries, the energy consumption must be reduced while considering the communication range and data rate requirements. In this context we analyze and compare, in this study, the UWB and TR-UWB system in terms of the total energy consumption. So, for that, we develop an analytical model to estimate the energy consumption of a … …Journal of Computer Science, Vol. 12, Issue 1 · 15 Feb 2016 · 7,317 accessesView PDF Cite

Research ArticleOpen accessIn the abstractATRA AS A POTENTIAL ANTIMETASTATIC AGENT IN COLORECTAL ADENOCARCINOMARobert Edwards, Kambiz Afrasiabi, Kehui WangThe family of Retinoic acid compounds have long been the subject of intense study and interest as chemo prophylactic agents. This dates back to their therapeutic effect in leukoplakia Where ATRA was shown to lead to the reversal of premalignant lesions and Subsequent reports on their use in metastatic colorectal adenocarcinoma and a vast array of other malignant disorders as … …OnLine Journal of Biological Sciences, Vol. 14, Issue 2 · 26 Mar 2014 · 7,344 accessesView PDF Cite

Research ArticleOpen accessIn the abstractRivaroxaban and its Effect on International Normalised Ratio-A Prospective Study of 28 Hip and Knee Arthroplasty PatientsV. Eranki, A. Pillai, G. Morrison, Cheng Hong YeoProblem statement: Rivaroxaban is an orally active, competitively reversible antagonist of activated factor Xa. The purpose of this study is to comment on Riveroxaban’s effect on INR. Approach: At the Queen Elizabeth Hospital, all patients undergoing elective anthroplasty were anticoagulated with 10mg of Rivaroxaban. All patients had INR measurements for 3 days post operatively. Further 16 patients had weekly INR … …Current Research in Medicine, Vol. 3, Issue 2 · 12 Jul 2012 · 21,044 accessesView PDF Cite

Research ArticleOpen accessIn the abstractTopical Cyclosporine A in Corneal Graft RejectionMahmood Nejabat, Jafar Khoshghadam, Masoomeh Eghtedari, Hamid HosseiniCorneal graft rejection is now the most common cause of graft failure after penetrating keratoplasty. This study was designed to determine whether, addition of 2% topical cyclosporine (CSA) to local and systemic steroids in treatment of endothelial corneal allograft rejection, would improve the outcome. A prospective randomized treatment trial was carried out on 40 consecutive corneal graft recipients, presenting with … …American Journal of Immunology, Vol. 2, Issue 2 · 30 Jun 2006 · 7,317 accessesView PDF Cite